These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 6997330)

  • 1. Prednisolone disposition in cushingoid and noncushingoid kidney transplant patients.
    Gambertoglio JG; Vincenti F; Feduska NJ; Birnbaum J; Salvatierra O; Amend WJ
    J Clin Endocrinol Metab; 1980 Sep; 51(3):561-5. PubMed ID: 6997330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different prednisolone pharmacokinetics in Cushingoid and non-Cushingoid kidney transplant patients.
    Bergrem H; Jervell J; Flatmark A
    Proc Eur Dial Transplant Assoc; 1983; 20():286-90. PubMed ID: 6361740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endogenous hydrocortisone, a possible factor contributing to the genesis of cushingoid habitus in patients on prednisone.
    Frey FJ; Amend WJ; Lozada F; Frey BM; Benet LZ
    J Clin Endocrinol Metab; 1981 Nov; 53(5):1076-80. PubMed ID: 7026594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prednisolone pharmacokinetics in cushingoid and non-cushingoid kidney transplant patients.
    Bergrem H; Jervell J; Flatmark A
    Kidney Int; 1985 Feb; 27(2):459-64. PubMed ID: 3887001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endogenous and exogenous glucocorticoids in cushingoid patients.
    Benet LZ; Frey FJ; Amend WJ; Lozada F; Frey BM
    Drug Intell Clin Pharm; 1982 Nov; 16(11):863-8. PubMed ID: 6756849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of prednisolone and endogenous hydrocortisone levels in cushingoid and non-cushingoid patients.
    Frey FJ; Amend WJ; Lozada F; Frey BM; Holford NH; Benet LZ
    Eur J Clin Pharmacol; 1981; 21(3):235-42. PubMed ID: 7032949
    [No Abstract]   [Full Text] [Related]  

  • 7. Exploratory study of total and free prednisolone plasma exposure and cushingoid appearance, quality of life and biochemical toxicity in adult male kidney transplant recipients.
    Bergmann TK; Isbel NM; Ostini R; Barraclough KA; Campbell SB; McWhinney BC; Inder WJ; Russell A; Staatz CE
    Clin Drug Investig; 2015 Nov; 35(11):743-50. PubMed ID: 26403249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of a radioreceptor assay in the assessment of cushingoid features in patients with juvenile rheumatic diseases.
    Lipnick RN; Morales A; Getson PR; White PH; Soldin SJ
    Ther Drug Monit; 1992 Apr; 14(2):169-72. PubMed ID: 1585405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical value of assessing prednisolone pharmacokinetics before and after renal transplantation.
    Ost L; Björkhem I; von Bahr C
    Eur J Clin Pharmacol; 1984; 26(3):363-9. PubMed ID: 6376143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Marked interspecies differences between humans and pigs in cyclosporine and prednisolone disposition.
    Frey BM; Sieber M; Mettler D; Gänger H; Frey FJ
    Drug Metab Dispos; 1988; 16(2):285-9. PubMed ID: 2898348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma prednisolone concentrations and kinetics in renal transplant patients.
    Nelson WE; Doherty CC; Douglas JF; McGeown MG; Delargy H; Temple DJ
    Proc Eur Dial Transplant Assoc; 1983; 19():544-51. PubMed ID: 6348752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disposition of total and unbound prednisolone in renal transplant patients receiving anticonvulsants.
    Gambertoglio JG; Holford NH; Kapusnik JE; Nishikawa R; Saltiel M; Stanik-Lizak P; Birnbaum JL; Hau T; Amend WJ
    Kidney Int; 1984 Jan; 25(1):119-23. PubMed ID: 6374250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Removal of prednisone and prednisolone by plasma exchange.
    Stigelman WH; Henry DH; Talbert RL; Townsend RJ
    Clin Pharm; 1984; 3(4):402-7. PubMed ID: 6467876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of 3 prednisolone prodrugs. Evidence of therapeutic inequivalence in renal transplant patients with rejection.
    Frey BM; Seeberger M; Frey FJ
    Transplantation; 1985 Mar; 39(3):270-4. PubMed ID: 3883592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The pharmacokinetics of prednisolone and prednisone in adult liver transplant recipients early after transplantation.
    Sæves I; Line PD; Bergan S
    Ther Drug Monit; 2012 Aug; 34(4):452-9. PubMed ID: 22777155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pharmacokinetics of prednisolone in renal transplant patients with or without Cushing's syndrome].
    Demotes-Mainard F; Potaux L; Aparicio M; de Précigout V; Vinçon G; Albin H
    Therapie; 1986; 41(6):449-54. PubMed ID: 3544323
    [No Abstract]   [Full Text] [Related]  

  • 17. The absence of effect of azathioprine on prednisolone pharmacokinetics following maintenance prednisone doses in kidney transplant patients.
    Gambertoglio JG; Holford HG; Lizak PS; Birnbaum JL; Salvatierra O; Amend WJ
    Am J Kidney Dis; 1984 May; 3(6):425-9. PubMed ID: 6372445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect on nephrotic syndrome on absorption and disposition of prednisolone in children.
    Rocci ML; Assael BM; Appiani AC; Edefonti A; Jusko WJ
    Int J Pediatr Nephrol; 1982 Sep; 3(3):159-66. PubMed ID: 7141787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exogenous Cushing syndrome from an unexpected source of systemic steroids.
    O'Brien KF; DeKlotz CMC; Silverman RA
    Pediatr Dermatol; 2018 May; 35(3):e196-e197. PubMed ID: 29574945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinetics and interconversion of prednisolone and prednisone studied with new radioimmunogassays.
    Meikle AW; Weed JA; Tyler FH
    J Clin Endocrinol Metab; 1975 Oct; 41(4):717-21. PubMed ID: 1176582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.